I must admit I'm thinking the same thing. I am wondering when institutions decide to pull the plug and cash out, I'd rather get out with 11 dollars than 9 dollars.
Other than the fact that these are both stocks with 4 letters in their ticker names, and they were both down at one point, there is no similarity.
I agree for the most part. Really they just need one every few years to work, and I think that will be biotest this year. 15 million will get them the opt in, and then its a matter of partnering the rest of their stuff so it doesn't hemorrhage while they try to get cash from their two main plays, kadcyla and bt-062.
Biotest buy in will come unexpectedly? Biotest is claiming it's a 2 billion dollar market, and i think for 10 million dollars IMGN can get half revenue- that buy in would add 8-10 dollars to the stock price as it would be better than kadcyla revenue currently.
Yes, they have gone home for the weekend, and I'm glad. It means that they won't mess up today. 3 more days where I don't have to worry about them messing up- and next week is july 4th so I can assume that's a 5 day weekend there for them where they won't drop the ball again either.
Yes, i am locked and loaded at this price, i picked up another couple thousand shares, several hundred calls and am ready to ride. Now, granted, I've #$%$ up buying IMGN in the past but I think the 11.60 level is the rallying level.
Famous last words.
That just doesn't seem realistic. I think we have a negative catalyst with this report that tanked the stock. There's such poor volume on it that it's easy to move. I was pretty happy yesterday watching IMGN cross 13.74 as the Merck deal was announced, so there are some people out there who would be willing to pay ~14 for IMGN. I think in 2 weeks we will put this Morgan Stanley report behind us and be knocking on 14's door again. The stock hasn't changed from yesterday in its fundamental value, it's just that no one really knows what the value is. I believe that we are getting closer and closer to having a pipeline or partnered product give us money, and if not, then some additional Kadcyla label expansion. It seems like these issues never really come, but are always being worked on. So I think the 2015 leap options seem like a good timeline to get in at.
In fact, I see the stock has hit 11.99 again on late afternoon selling. I'm surprised that it didn't go down to 11.88 with the way that IMGN usually sucks during a bear attack. I'm keeping my fingers crossed that get some late volume and end up at 12.30 or so, the 50 day SMA.
How many did you get? I also picked them up, i wonder if you and are the only two who purchased these today. There's only 52 contracts transacted today, and I got 30.
Yeah good point. It looks like futures are down at this point, it would not surprise me to see it open 100 pts down tomorrow, that seems to be the typical 2 day follow through pattern of international conflicts.
Yaleloe: tomorrow is the annual shareholder meeting.
but then if it's sold for 200M, NOLs get fixed at 200Million, which is only worth 0.35*200M= 70 million once you use it to offset earnings at a 35% tax rate. The other 130 million in value are from the patent portfolio? Or the drug? I don't agree.
Referring to it as CD209 when it's a CD206 ligand, and a couple other small things could polish up his talk. I didn't notice anything new in there, and I think we are currently holding our breath for the EMA ruling later this week or the announcement of a partnership.
can you explain what is in those filings? I skimmed them over but wasn't clear on what is happening with the rights agreement.
no, looking to hold long term, building a position, it just looked like 6.4 was a pretty good support level. it would just be nice if, for once when building up a position, it would move in the positive direction. Then again, I guess if that were the case I'd never buy more.
super light volume on this move down, i'll bet a few people are spooked by the iraq issue that came up mid day, and the fact that the shareholder meeting is a general 'unknown'.
If it was an institution, we'd be at way higher than 2 million for the day